Tatos is working on the Clp protease system of Mycobacterium tuberculosis (Mtb) – a high priority target for drug development.
Emmy Dove
Emmy handles managerial responsibilities for the lab. These include ordering supplies, managing safety trainings, maintaining equipment, and shipping materials to collaborators.
Kristi Guinn
Kristi (not a slave to fashion) Guinn has been keenly interested in TB since 2000. She did her Master’s work studying genetic determinants of pathogenicity, and migrated away from the bench shortly thereafter to try her hand at project management. She has happily remained in this capacity, joining the Rubin Lab in 2011.
Olga Kandror
Olga is working on the Clp protease system of Mycobacterium tuberculosis (Mtb) – a high priority target for drug development.
Jackson Marakalala
Mohlopheni (Jackson) is interested in host factors that drive lung granuloma progression in TB patients. He is also interested in genes utilized by M. tuberculosis to subvert macrophage killing effects. Office: University of Cape Town, Cape Town, South Africa
Kerry McGowen
Kerry is studying the characteristics and genes involved in the development of Mycobacterium abscessus biofilms.
Jessica T. Pinkham Schweber
Jess joined the Rubin Lab in 2009 and has been involved with multiple projects since then, but has mainly contributed to work investigating genes that are essential for growth in M. tuberculosis, with a special focus on potential drug targets.
Mark Sullivan
Mark is studying Mycobacterium abscessus lung infection through the use of tissue culture model systems.
Shoko Wakabayashi
Ian Wolf
Ian’s research focuses on genes of unknown function in tuberculosis.
Harim Won
Harry is studying targeted protein degradation as a Mycobacterium tuberculosis antibiotic development strategy.
Lixin Zhang
Office: Chinese Academy of Sciences, Beijing, China
Junhao Zhu
Junhao targets specific, high throughput anti-TB small molecule screening using a DNA encoded drug library and synthetic mitochondria.
